Why it can take time and effort to find the right meds to help mental health

The Long, Uncertain Road to Finding the Right Mental Health Medication

Healfromzero.com – For roughly one in five American adults, a prescription pad plays a central role in managing depression, anxiety, or another psychiatric condition. The Centers for Disease Control and Prevention estimates that nearly 20% of adults in the United States currently take at least one medication aimed at their mental health. Yet the path from diagnosis to effective treatment is rarely straightforward. Brain disorders are among the most complex conditions in all of medicine, and the pharmacological tools available to clinicians operate through mechanisms that unfold over weeks, sometimes months. Deciding when a particular drug is failing, when to adjust a dose, or when to pivot to an entirely different class of compound demands patience, close monitoring, and sustained dialogue between patient and prescriber.

Nowhere is that complexity more painfully visible than in the aftermath of a case that has gripped the public imagination: the trial of Lindsay Clancy, a 36-year-old labor and delivery nurse who, in 2023, strangled her three young children, cut her own wrists and throat, and leapt from a second-story window. In the days leading up to the tragedy, Clancy had been cycling through dozens of prescriptions for depression, anxiety, and related conditions. Mental health professionals who had treated her testified at trial that she repeatedly requested changes to her regimen. On the day before the killings, she typed a message into her phone that prosecutors briefly displayed to the jury:

“Medication stole my motherhood and my life.”

Two Sides of the Same Question

Clancy’s defense attorney, Kevin Riddington, framed the case around a diagnosis of postpartum psychosis — a rare condition that, when untreated, carries a statistically elevated risk of infanticide and suicide, according to published research. In his closing argument, delivered while Clancy sat at the defense table nodding, Riddington argued that his client had been overmedicated and was not criminally responsible for what happened because she was in a psychotic state.

“She was reaching out for help, and she was not getting it,” Riddington told the jury.

Prosecutor Jennifer Sprague offered a sharply different reading. She pointed to what she described as premeditated behavior in the manner of the killings, argued that Clancy understood the difference between right and wrong, and contended that the nurse had misled her mental health providers and failed to take medications as directed.

“She knows, as a nurse, the importance of following the instructions of your medications,” Sprague said.

Since the trial, Clancy has filed suit against her treating physicians. The lawsuit alleges that rather than arriving at a proper diagnosis, the providers “subjected her to a disorganized, uncoordinated course of polypharmacy that exacerbated her condition and precipitated a severe psychotic break.” All previously involved providers declined to comment while litigation is pending.

Dr. Joseph Goldberg, a psychiatrist and psychopharmacologist with no connection to the case, offered a broader perspective on what the trial reveals about psychiatric care in general.

“It has been an opportunity to remind us all about the complexities of severe mental illness and the complexities of treating mental illness,” Goldberg said.

How the Major Drug Classes Actually Work

Mental health pharmacology is typically organized into four or five broad categories, each targeting different neurotransmitter systems and clinical presentations. Understanding these mechanisms helps patients set realistic expectations and engage more productively with their prescribers.

Antidepressants: SSRIs, NDRIs, and SNRIs

Selective serotonin reuptake inhibitors — commonly known by brand names such as Celexa, Prozac, and Zoloft — remain the first-line pharmacological intervention for a wide spectrum of depressive and anxiety disorders. They are regarded as highly effective, and their side-effect profile tends to be mild: transient stomach upset, diminished libido, and occasional headaches that often attenuate over time. The critical caveat is time. Because SSRIs modify how the brain processes serotonin, the neurotransmitter implicated in mood regulation, sleep architecture, and appetite, therapeutic benefit generally requires four to eight weeks of consistent use. An exception exists for menstrual-cycle-related mood disturbances, where hormonal interactions with brain chemistry can accelerate onset.

At the cellular level, many depressive disorders respond to SSRIs because the drugs block the rapid reuptake of serotonin back into presynaptic cells. Serotonin therefore remains active in the synaptic cleft for a longer window. Over successive weeks, the brain compensates by desensitizing certain receptor populations. That downstream adaptation triggers the release of brain-derived neurotrophic factor, a protein that functions somewhat like fertilizer for neural tissue, encouraging the growth of new neurons and synaptic connections and gradually lifting mood.

A second antidepressant family, the norepinephrine-dopamine reuptake inhibitors (NDRIs), exemplified by bupropion, blocks the reabsorption of norepinephrine and dopamine — neurotransmitters tied to stress response, pleasure, reward processing, alertness, and sustained attention. A third family, the serotonin-norepinephrine reuptake inhibitors (SNRIs), including Cymbalta, Fetzima, and Effexor XR, inhibits the reuptake of both serotonin and norepinephrine, thereby modulating the body’s fight-or-flight circuitry alongside mood regulation.

Anti-Anxiety Medications: Speed Versus Sustainability

Benzodiazepines such as Ativan, Librium, Xanax, and Valium occupy a distinct niche. They can ease acute episodes of extreme worry, terror, social anxiety, or panic within minutes of ingestion. That rapid onset is precisely why clinicians reserve them for short-term use: dependence develops with continued exposure, and the drugs carry dangerous side effects when they depress nervous-system activity beyond a safe threshold. They are stabilizing bridges, not long-term foundations.

What Patients and Families Should Take Away

The Clancy trial, whatever its ultimate verdict, underscores a reality that psychiatrists have long emphasized: there is no algorithm that guarantees the correct medication on the first attempt. Polypharmacy — stacking multiple agents simultaneously — can obscure which compound is helping, which is harming, and which interactions are amplifying side effects. Patients who feel their regimen is chaotic, who experience worsening symptoms despite adherence, or who sense that their prescriber is not listening, are justified in seeking a second opinion or requesting a structured medication review. The goal is not to avoid medication, but to ensure that each molecule in the regimen earns its place through clear clinical rationale, monitored response, and honest communication between patient and doctor.